The woman at high risk for breast cancer: Importance of hyperplasia

Surgical Clinics of North America

Volumn 76, Issue 2, 1996, Pages 221-230

  Page, D L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CANCER RISK; CARCINOMA IN SITU; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0029924361     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70435-7     Document Type: Article

References (43)

1. C.S. Abendroth H.H. Wang B.S. Ducatman Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens Am J Clin Pathol 96 1991 654 659
2. D.C. Allred P. O'Connell S. Fuqua Biomarkers in early breast neoplasia J Cell Biochem 53 1993 125 131
3. J. Azzopardi Problems in Breast Pathology 1979 WB Saunders Philadelphia
4. C. Bellamy C. McDonald D.M. Salter Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization Hum Pathol 24 1993 16 23
5. W.L. Betsill P.P. Rosen P.H. Lieberman Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone JAMA 239 1978 1863 1867
6. W.D. Dupont Converting relative risks to absolute risks: A graphical approach Stat Med 8 1989 641 651
7. W.D. Dupont D.L. Page Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer Am J Epidemiol 125 1987 769 779
8. W.D. Dupont D.L. Page Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia Hum Pathol 20 1989 723 725
9. W.D. Dupont D.L. Page Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 1985 146 151
10. W.D. Dupont D.L. Page L.W. Rogers Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk Cancer 63 1989 948 957
11. W.D. Dupont F.F. Parl W.H. Hartmann Breast cancer risk associated with proliferative breast disease and atypical hyperplasia Cancer 71 1993 1258 1265
12. V. Eusebi E. Feudale M.P. Foschina Long-term followup of in situ carcinoma of the breast Semin Diagn Pathol 11 1994 223 225
13. V. Eusebi M.A. Foschini M.G. Cook Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma Semin Diag Pathol 6 1989 165 173
14. F.W. Foote F.W. Stewart Lobular carcinoma in situ Am J Pathol 17 1941 491 495
15. R. Hutter Consensus meeting Is “fibrocystic disease” of the breast precancerous? Arch Pathol Lab Med 110 1986 171 173
16. P.T. Kelly Understanding breast cancer risk 1991 Temple University Press Philadelphia
17. M.D. Lagios Duct carcinoma in situ: Pathology and treatment Surg Clin North Am 70 1990 853 871
18. M.D. Lagios F.R. Margolin P.R. Westdahl Mammographically detected duct carcinoma in situ Cancer 63 1989 618 624
19. W.J. Lennington R.A. Jensen L.W. Dalton Ductal carcinoma in situ of breast: Heterogeneity of individual lesions Cancer 73 1994 118 124
20. S.J. London J.L. Connolly S.J. Schnitt A prospective study of benign breast disease and risk of breast cancer JAMA 267 1992 941 944
21. M. Morrow Pre-cancerous breast lesions: Implications for breast cancer prevention trials Int J Radiat Oncol Biol Phys 23 1992 1071 1078
22. D.L. Page T.J. Anderson L.W. Rogers Epithelial hyperplasia D.L. Page T.J. Anderson Diagnostic Histopathology of the Breast 1988 Churchill Livingstone Edinburgh 120 156
23. D.L. Page W.D. Dupont Anatomic indicators (histologic and cytologic) of increased cancer risk Breast Cancer Res Treat 28 1993 157 166
24. D.L. Page W.D. Dupont Anatomic markers of human premalignancy and risk of breast cancer Cancer 66 1990 1326 1335
25. D.L. Page W.D. Dupont Histologic indicators of breast cancer risk Bull Am Coll Surg 76 9 1991 16 23
26. D.L. Page W.D. Dupont Proliferative breast disease: Diagnosis and implications Science 253 1991 915
27. D.L. Page W.D. Dupont L.W. Rogers Breast cancer risk of lobular-based hyperplasia after biopsy: “Ductal” pattern lesions Cancer Detect Prev 9 1986 441 448
28. D.L. Page W.D. Dupont L.W. Rogers Intraductal carcinoma of the breast: Follow-up after biopsy only Cancer 49 1982 751 758
29. D.L. Page W.D. Dupont L.W. Rogers Atypical hyperplastic lesions of the female breast. A long-term follow-up study Cancer 55 1985 2698 2708
30. D.L. Page T.E. Kidd W.D. Dupont Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease Hum Pathol 22 1991 1232 1239
31. D.L. Page L.W. Rogers Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia Hum Pathol 23 1992 1095 1097
32. D.L. Page C.M. Steel J.M. Dixon ABC of breast diseases: Carcinoma in situ and patients at high risk of breast cancer BMJ 310 1995 39 42
33. D. Palli M. Rosselli del Turco Benign breast disease and breast cancer: A case-control study in a cohort in Italy Int J Cancer 47 1991 703 706
34. S.H. Parker F. Burbank R.J. Jackman Percutaneous large-core breast biopsy: A multi-institutional study Radiology 193 1994 359 364
35. P.P. Rosen R.T. Senie G.H. Farr Epidemiology of breast carcinoma: Age, menstrual status and exogenous hormone usage in patients with lobular carcinoma in situ Surgery 85 1979 219 224
36. S.J. Schnitt J.L. Connolly F.A. Tavassoli Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria Am J Surg Pathol 16 1992 1133 1143
37. G.F. Schwartz G.C. Finkel J.C. Garcia Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone Cancer 70 1992 2468 2474
38. R.B. Shack D.L. Page The patient at risk for breast cancer: Pathologic and surgical considerations Perspect Plast Surg 2 2 1988 43 62
39. M.J. Silverstein D.N. Poller J.R. Waisman Prognostic classification of breast ductal carcinoma in situ Lancet 345 1995 1154 1157
40. N. Sneige G.A. Staerkel Fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ Hum Pathol 25 1994 485 492
41. M.W. Stanley S.M. Henry R. Zera Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium Hum Pathol 24 1993 630 635
42. F.A. Tavassoli H.J. Norris A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast Cancer 65 1990 518 529
43. S.R. Wellings H.M. Jensen R.G. Marcum An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions J Natl Cancer Inst 55 1975 231 273